Just Other Articles

Considering a second or third generation website? Embark on the following r

According to USFDA, a combination product is one composed of any combination of a drug and device; biological product and device; drug and biological product

eview process to fine-tune your next steps.

Web Site Evaluation
; or drug, device, and biological product and fixed dose combination would include two or more combinations of drug.

Examples of combination products may in
rong>

• Overall Impact of the Project

1. Does
lude drug-coated devices, drugs packaged with delivery devices in medical kits, and drugs and devices packaged separately but intended to be used together.

the site (content and functionality) achieve the goals that you have define
here is enormous increase in the number of combination products entering the market in the recent years. Combination products have proven advantages but fixe
d?
2. Are you tracking the right outcomes to ensure that you are meetin
d dose combinations are still in the process of convincing regulatory authority on their advantages over the single ingredient formulations.

Combination pro
g your goals?
3. What feedback have you received?
4. What works be
ucts have become life saving products for the pharmaceutical companies who doesn’t have many innovative molecules in their product pipeline and have been inc
st on this site?
5. What needs improvement?
6. Does the site take
easingly used in the product life cycle management. Even the companies having product patents are trying to extend their product life cycle through the combi
advantage of current tools that may improve usefulness and increase effectiv
nation products and maximize the revenues. But the companies involved in this practice are overlooking that they are burdening the patients both economically
eness in terms of meeting organizational goals?

• Design/Vis
and physically. They need to rightly judge the benefits of the combination products and they have to even look at the risks involved when combining the produ
ual Appeal

1. Is the design attractive, appropriate, and cons
ts. Some of the combination products were well accepted by physicians while others suffered. Companies involved in development of combination products are fi
stent with your image as conveyed in print and other media?
2. Does it
ding difficulty in defining their combination products and facing various challenges from selecting a combination to marketing it.

Following aspects would a
direct users to the information they need?
3. How do content and design
dd to the challenges in developing combination products:

Which markets to tap where the combination products can do fairly well?
Which combination prod
work together: Do they reinforce each other, or compete?
4. Do graphic
cts are meaningful and rational?
Which therapeutic categories to select?
Which Combinations can address unmet needs of the patients?
Do combin
s load quickly and consistently on all current browsers and common Internet
tions increase the patient compliance?
What would be the developing cost?
How to tackle the risks encountered during combination product developmen
access speeds?

• Interaction/Use of Medium

t?

As combination products don't fit into the traditional categories of drugs, medical devices, or biological products, the USFDA is in the process of devel
1. How well has the content been adapted/created to work in the Web medium?<
ping new procedures for reviewing their safety, efficacy and quality.

Professional from academic institutions, pharmaceutical industries, health care indust
br> 2. Does the site encourage user feedback and action where relevant?
y and representatives from various regulatory agencies are working out to design the regulatory requirements for manufacture and sale of combination products
3. Does the site offer opportunity for soliciting information from users a
.

As there is an increasing trend of the combination products companies manufacturing such products should be able to tackle the problems involved in the de
nd involving users in interactions that will encourage their continued activ
elopment. They need to be wiser in analyzing the market trends and the regulatory requirements.

Companies that provide selfless information through particip
e involvement with your organization, including their return to the site?

tion in industry events and feedback to regulatory authorities would be able to face the challenges and will be successful in developing combination products

Tags

Links

Just Other Articles - How to Evaluate Your Nonprofit Website

Related Articles: